Cover image not available

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology appraisal No. 111) : a systematic review a

Publication Data

Title The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology appraisal No. 111) : a systematic review a
Contributors M. Bond, NIHR Evaluation, Trials and Studies Coordinating Centre, NIHR Health Technology Assessment Programme
Publisher Prepress Projects Ltd. on behalf of NETSCC, HTA
Publication date 2012
Publication location Perth
Language English

Topics

Alzheimer's disease :: Chemotherapy :: Cost-effectiveness
Acetylcholinesterase :: Effectiveness
Clinical trials :: Great Britain

Catalogue Data

OBNB ID GBB263040
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.831061

ISBD

P1053 xix, 469 p.
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology appraisal No. 111) : a systematic review a. Published by Prepress Projects Ltd. on behalf of NETSCC, HTA in 2012. Publication and catalogue information, links to buy online and reader comments.